Peer Review #1 of "Prolonged pituitary down-regulation with full-dose of gonadotropin-releasing hormone agonist in different menstrual cycles: a retrospective cohort study (v0.1)"
peer-review
OA: gold
CC0
Abstract
Background:The efficiency of prolonged down-regulation caused by a full-dose of gonadotropin-releasing hormone agonist (GnRH-a) injected during different menstrual phases has not yet been researched.Our goal was to evaluate the effects of GnRH-a, which was used in different phases of the menstrual cycle in patients undergoing in vitro fertilization and embryo transfer (IVF-ET).Methods: This was a retrospective cohort study.Three hundred and twenty patients received a prolonged pituitary down-regulated fulldose (3.75mg) of triptorelin in the early follicular phase, and 160 patients received the same full-dose of triptorelin during the mid-luteal phase.Clinical and laboratory outcomes were compared between the two groups.Results: The basic characteristics of the two groups were comparable.The mean number of retrieved oocytes, fertilized oocytes, cleavage oocytes and good quality embryos were comparable between the two groups.Although there was a higher antral follicle count (AFC), cyst formation rate, fertilization rate and cleavage rate in the follicular phase group, no statistically significant effects were seen on implantation rate (41.15% vs. 45.91%),clinical pregnancy rate (60.38% vs. 61.36%),ongoing pregnancy rate (57.74% vs. 57.58%),live birth rate (56.23% vs. 57.58%)or early abortion rate (2.64% vs. 3.79%) per fresh transfer cycle.Moreover, severe ovarian hyper-stimulation syndrome (OHSS) rates at the early stage (1.89% vs. 2.27%) were low in both groups.Conclusions: Prolonged pituitary down-regulation achieved by utilizing a full-dose of GnRH-a administrated in either phase of the menstrual cycle can have a positive effect on ongoing pregnancy rate and live-birth rate per fresh embryo transfer cycle.Ovarian cyst formation rate was higher in the follicular phase group, but this did not have any adverse impact on clinical results.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment? 2014
- A novel approach using a minimal number of injections during the IVF/ICSI cycle: Luteal half-dose depot GnRH agonist following corifollitropin alfa versus the corifollitropin alfa with a GnRH-antagonist cycle 2016
References (27)
- A novel approach using a minimal number of injections during the IVF/ICSI cycle: Luteal half-dose depot GnRH agonist following corifollitropin alfa versus the corifollitropin alfa with a GnRH-antagonist cycle via openalex
- Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment? via openalex
- W1893486843 via openalex
- W2010043175 via openalex
- W2029615947 via openalex
- W2031648622 via openalex
- W2034198566 via openalex
- W2089156576 via openalex
- W2103087022 via openalex
- W2131594873 via openalex
- W2134480221 via openalex
- W2161516704 via openalex
- W2182271449 via openalex
- W2188474525 via openalex
- W2213021570 via openalex
- W2309215091 via openalex
- W2336265739 via openalex
- W2366487049 via openalex
- W2444517199 via openalex
- W2620425946 via openalex
- W2777178149 via openalex
- W4231021509 via openalex
- W4288400169 via openalex
- W4297913340 via openalex
- W188284279 via openalex
- W6921940618 via openalex
- W1491610655 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK